OWL vs IVZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

OWL

61.4
AI Score
VS
IVZ Wins

IVZ

68.9
AI Score

Investment Advisor Scores

OWL

61score
Recommendation
BUY

IVZ

69score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric OWL IVZ Winner
Revenue 3.57B 275.07M IVZ
Net Income 558.00M 26.93M IVZ
Net Margin 15.6% 9.8% IVZ
ROE 4.5% 1.3% IVZ
ROA 2.0% 0.2% IVZ
Total Assets 27.47B 12.33B IVZ
Cash 915.40M 169.06M IVZ
Debt/Equity 0.13 1.91 IVZ
Free Cash Flow 902.10M 541.93M IVZ

Relative Price Performance (Last 90 Days)

OWL 1M: +1.1% · 3M: +2.8% IVZ 1M: -6.3% · 3M: -3.8%

Current Technical Phase

OWL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.3 · Price: $9.71

IVZ

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.1%), weak momentum, RSI 41

RSI (14): 40.9 · Price: $28.79

Fundamentals Snapshot

Metric OWL IVZ
Market Cap — —
Forward P/E 9.9 8.8
Trailing P/E 76.4 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.2%
Gross Margin 0.6% 0.3%
Operating Margin 0.3% 0.2%
EPS 0.12 -0.68
Dividend Yield 0.10% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IVZ is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.